On Wednesday, April 12, the United States announced its designation as “emerging threat” xylazine, aka “calm”, in particular to be able to disburse money to combat this drug that is already wreaking havoc in the country. The point about this article that worries the US authorities.
• sedative and analgesic veterinary
Xylazine, authorized as a veterinary analgesic and analgesic since 1972 by the US Drug Administration (FDA), is not approved outside of animal use.
sequel after announcement
In humans, its consumption can slow breathing and heart rate to dangerous levels, cause infections or even “severe skin necrosis” in repeated consumption, potentially leading to amputations.
Between 2020 and 2021, detections of xylazine by the US Drug Enforcement Agency (DEA) increased by nearly 200% in the south of the country, and more than 100% in the west.
Vancouver drug decriminalization: “Saving a life every day is worth it”
This drug is now known as “calm” or “tranq dope”– l “soothing” – Or the “zombie drug,” because of the lethargic effect to which xylazine immerses its consumers, as The New York Times explains.
Its use as a drug may have begun in 2000 in Puerto Rico, according to a BFMTV report, which cites use of the substance as Philly, a drug prevention association in Philadelphia.
sequel after announcement
• An action plan is being developed
“This is the first time in our nation’s history that a substance has been classified as an emerging threat.”Dr. Rahul Gupta, director of the Office in Charge of Drug Control at the White House, said at a news conference.
The designation as an emerging threat, Rahul said, is the use of funds President Joe Biden has requested from the US Congress in his 2024 budget.
Gupta.
‘Cocaine Makes You Become World Champion’: How Cocaine Became France’s Second Drug
We need the support of Congress.so that you do not have to redirect funds allocated to other causes. “It’s not a country problem.” democrats or republicans, ‘It’s America’s problem’Knock.
The government is required, within three months of the appointment, to submit an action plan to Congress, which will address several areas. Among them: more testing to discover the drug and analyzes to better understand its source – especially if it was diverted in the US or from China – in order to better combat its growing presence in the illegal market.
• “Need an antidote”
Another priority is medical research. “We will bring together national experts in the field to guide practice and identify the most promising approaches for clinical stabilization, withdrawal management, and treatment protocols.”Rahul Gupta in detail.
sequel after announcement
Furthermore it, ‘We need an antidote’He added that the matter does not exist yet.
“Record Abstinence: A Week and a Half,” Vancouver tries to bet on decriminalizing hard drugs
Naloxone, an antidote that can resuscitate a person during an opioid overdose (such as fentanyl), is not effective against xylazine. Fentanyl and xylazine, both synthetic, are often found together in the same product, according to the Drug Enforcement Administration.
In February, US health authorities released a “import alert” In order to better control deliveries of xylazine, to ensure that it is indeed intended for veterinary use.
